BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27703007)

  • 1. Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling: A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS.
    Speen AM; Kim HH; Bauer RN; Meyer M; Gowdy KM; Fessler MB; Duncan KE; Liu W; Porter NA; Jaspers I
    J Biol Chem; 2016 Nov; 291(48):25192-25206. PubMed ID: 27703007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of trophoblast survival and differentiation by LXR ligands is prevented by cholesterol but not ABCA1 silencing.
    Harmon CM; McGonigal S; Larkin JC
    Placenta; 2018 Sep; 69():50-56. PubMed ID: 30213484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of statins and the synthetic LXR agonist T0901317 on expression of ABCA1 transporter protein in human lung epithelial cell lines in vitro.
    He P; Smith A; Gelissen IC; Ammit AJ
    Pharmacol Rep; 2019 Dec; 71(6):1219-1226. PubMed ID: 31669886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterols Modify NLRP2 in Epithelial Cells, Identifying a Mediator of Ozone-induced Inflammation.
    Perryman A; Speen AM; Kim HH; Hoffman JR; Clapp PW; Rivera Martin W; Snouwaert JN; Koller BH; Porter NA; Jaspers I
    Am J Respir Cell Mol Biol; 2021 Nov; 65(5):500-512. PubMed ID: 34126877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
    Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X Receptor Activation Attenuates Oxysterol-Induced Inflammatory Responses in Fetoplacental Endothelial Cells.
    George M; Lang M; Gali CC; Babalola JA; Tam-Amersdorfer C; Stracke A; Strobl H; Zimmermann R; Panzenboeck U; Wadsack C
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VD
    Munir MT; Ponce C; Santos JM; Sufian HB; Al-Harrasi A; Gollahon LS; Hussain F; Rahman SM
    Mol Biol Rep; 2020 Oct; 47(10):7771-7782. PubMed ID: 32990902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
    Kaseda R; Tsuchida Y; Yang HC; Yancey PG; Zhong J; Tao H; Bian A; Fogo AB; Linton MRF; Fazio S; Ikizler TA; Kon V
    BMC Nephrol; 2018 Jan; 19(1):17. PubMed ID: 29374468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.
    Shrestha E; Hussein MA; Savas JN; Ouimet M; Barrett TJ; Leone S; Yates JR; Moore KJ; Fisher EA; Garabedian MJ
    J Biol Chem; 2016 May; 291(21):11172-84. PubMed ID: 27026705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
    Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
    Murthy S; Born E; Mathur SN; Field FJ
    J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection.
    Ramezani A; Dubrovsky L; Pushkarsky T; Sviridov D; Karandish S; Raj DS; Fitzgerald ML; Bukrinsky M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):376-83. PubMed ID: 26126533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
    Trasino SE; Kim YS; Wang TT
    Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin enhances oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transporters.
    Monzel JV; Budde T; Meyer Zu Schwabedissen HE; Schwebe M; Bien-Möller S; Lütjohann D; Kroemer HK; Jedlitschky G; Grube M
    Biochem Pharmacol; 2017 Nov; 144():108-119. PubMed ID: 28807695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of liver X receptor agonist TO901317 on cognitive function in APP/PS1 double transgenic mice with Alzheimer
    Luo Y; Tan X; Zhang X; Li Y; Huang J; Deng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1324-1331. PubMed ID: 36411683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
    Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
    Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.